Capital Advisors Inc. OK Has $266,000 Stock Holdings in Humana Inc. (NYSE:HUM)

Capital Advisors Inc. OK decreased its position in Humana Inc. (NYSE:HUM) by 26.6% during the fourth quarter, HoldingsChannel reports. The firm owned 1,050 shares of the insurance provider’s stock after selling 381 shares during the quarter. Capital Advisors Inc. OK’s holdings in Humana were worth $266,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Creative Financial Designs Inc. ADV raised its holdings in Humana by 244.0% in the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 61 shares during the period. Ashton Thomas Securities LLC acquired a new stake in shares of Humana in the third quarter valued at about $31,000. Your Advocates Ltd. LLP increased its stake in shares of Humana by 81.8% in the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock worth $32,000 after purchasing an additional 45 shares during the period. Atwood & Palmer Inc. lifted its position in shares of Humana by 64.5% during the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock worth $39,000 after purchasing an additional 60 shares during the last quarter. Finally, LRI Investments LLC boosted its stake in Humana by 1,021.4% during the 3rd quarter. LRI Investments LLC now owns 157 shares of the insurance provider’s stock valued at $50,000 after purchasing an additional 143 shares during the period. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the transaction, the insider now owns 8,181 shares in the company, valued at approximately $2,096,463.06. The trade was a 31.16 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.32% of the stock is owned by company insiders.

Analysts Set New Price Targets

HUM has been the topic of several recent analyst reports. Morgan Stanley dropped their price target on Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research report on Wednesday. Cantor Fitzgerald reiterated a “neutral” rating and set a $290.00 target price on shares of Humana in a research note on Wednesday. Barclays increased their price target on shares of Humana from $253.00 to $255.00 and gave the company an “equal weight” rating in a report on Wednesday, January 22nd. Bank of America upgraded shares of Humana from an “underperform” rating to a “neutral” rating and boosted their price objective for the stock from $247.00 to $308.00 in a report on Wednesday, November 6th. Finally, Wells Fargo & Company cut their price objective on shares of Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a research report on Monday, November 4th. Nineteen analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $292.26.

Humana Stock Up 1.0 %

Shares of NYSE HUM opened at $259.93 on Thursday. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $406.46. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The business has a fifty day moving average of $273.00 and a two-hundred day moving average of $295.72. The stock has a market cap of $31.30 billion, a PE ratio of 23.02, a PEG ratio of 2.11 and a beta of 0.56.

Humana (NYSE:HUM) last announced its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.18% and a return on equity of 13.20%. As a group, equities research analysts expect that Humana Inc. will post 16.11 earnings per share for the current fiscal year.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.